Duke University is planning a clinical trial on 12- to 18-year-olds who are patients at the Duke Child and Adolescent Gender Care Clinic. The study is estimated to start in September 2022 (next month).
The innocuous-seeming summary:
Disordered sleep is a health issue with significant impacts on physical and psychological well-being that has increased in prevalence, but its impact on transgender adolescents has not been fully quantified. While there is found to be an impact of sex steroids on sleep, and sex-dependent differences in the impact of sleep duration and quality on insulin resistance (IR), there is limited available information regarding the impact of Gender Affirming Hormone Therapy (GAHT) for transgender individuals on sleep and IR. Our study aims to quantify the impacts of GAHT on sleep and IR in the pediatric transgender population as well as determine the degree of correlation of sleep to IR in this population.
Where are the clinical trials showing that puberty blockers and wrong-sex hormones are effective treatments for any kind of valid condition?